359 related articles for article (PubMed ID: 29565948)
21. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
[TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2013 Mar; (3):CD007963. PubMed ID: 23543558
[TBL] [Abstract][Full Text] [Related]
23. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
Satoh J; Yagihashi S; Baba M; Suzuki M; Arakawa A; Yoshiyama T; Shoji S
Diabet Med; 2011 Jan; 28(1):109-16. PubMed ID: 21166852
[TBL] [Abstract][Full Text] [Related]
25. 0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
Kulkantrakorn K; Chomjit A; Sithinamsuwan P; Tharavanij T; Suwankanoknark J; Napunnaphat P
J Clin Neurosci; 2019 Apr; 62():174-179. PubMed ID: 30472337
[TBL] [Abstract][Full Text] [Related]
26. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
[TBL] [Abstract][Full Text] [Related]
27. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
Nalamachu S; Hale M; Khan A
J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
[TBL] [Abstract][Full Text] [Related]
28. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T; Katayama Y; Hiasa Y; Nishihara M; Tajima F; Katoh S; Tanaka H; Maeda T; Furusawa K; Richardson M; Kakehi Y; Kikumori K; Kuroha M
Neurology; 2023 Mar; 100(11):e1193-e1206. PubMed ID: 36517235
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.
Semenchuk MR; Sherman S; Davis B
Neurology; 2001 Nov; 57(9):1583-8. PubMed ID: 11706096
[TBL] [Abstract][Full Text] [Related]
30. Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study.
Motilal S; Maharaj RG
J Altern Complement Med; 2013 Apr; 19(4):347-52. PubMed ID: 23098698
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
Silver M; Blum D; Grainger J; Hammer AE; Quessy S
J Pain Symptom Manage; 2007 Oct; 34(4):446-54. PubMed ID: 17662571
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
33. Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain.
Nalamachu S; Ruck D; Nalamasu R; Fasbinder S; Bansal R
J Opioid Manag; 2013; 9(1):43-9. PubMed ID: 23709303
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.
Parsons B; Li C
Curr Med Res Opin; 2016 May; 32(5):929-37. PubMed ID: 26854578
[TBL] [Abstract][Full Text] [Related]
35. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
38. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Toth C; Mawani S; Brady S; Chan C; Liu C; Mehina E; Garven A; Bestard J; Korngut L
Pain; 2012 Oct; 153(10):2073-2082. PubMed ID: 22921260
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
Wallace MS; Rowbotham MC; Katz NP; Dworkin RH; Dotson RM; Galer BS; Rauck RL; Backonja MM; Quessy SN; Meisner PD
Neurology; 2002 Dec; 59(11):1694-700. PubMed ID: 12473754
[TBL] [Abstract][Full Text] [Related]
40. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
